HIV/AIDS treatment programmes using drug cocktails that are standard in the industrialised world are proving less effective in developing countries, says a study published in The Lancet today (10 March). It shows that people taking the cocktail, known as HAART, are more likely to die in the first few months of treatment if they live in poorer countries.